| Literature DB >> 35434130 |
Naser Nazari1, Bahareh Kordi2, Bahman Maleki3, Morteza Shams4, Esfandiar Azizi5, Hamidreza Majidiani2, Razi Naserifar4.
Abstract
Prevention of neosporosis is advantageous for cattle health and productivity. Previously, several vaccine candidates were nominated for vaccination against Neospora caninum. This study was premised on in silico evaluation of N. caninum IMP-1 in order to determine its physicochemical features and immunogenic epitopes. We employed a wide array of network-based tools for the prediction of antigenicity, allergenicity, solubility, posttranslational modification (PTM) sites, physicochemical properties, transmembrane domains and signal peptide, secondary and tertiary structures, and intrinsically disordered regions. Also, prediction and screening of potential continuous B cell peptides and those epitopes having stringent affinity to couple with mouse major histocompatibility complex (MHC) and cytotoxic T lymphocyte (CTL) receptors were accomplished. The protein had 393 residues with a molecular weight of 42.71 kDa, representing aliphatic index of 85.83 (thermotolerant) and GRAVY score of -0.447 (hydrophilic). There were 47 PTM sites without a signal peptide in the sequence. Secondary structure comprised mostly of extended strand and helices, followed by coils. The Ramachandran plot of the refined model showed 90.1%, 9.9%, 0.0%, and 0.0% residues in the favored, additional allowed, generously allowed, and disallowed regions, correspondingly. Additionally, various potential B cell (linear and conformational), CTL, and MHC binding epitopes were predicted for N. caninum IMP-1. The findings of the present study could be further directed for next-generation vaccine design against neosporosis.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35434130 PMCID: PMC9010208 DOI: 10.1155/2022/2508050
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Computed solubility (a) and subcellular localization (b) of the NcIMP-1 protein.
Figure 2Secondary structure prediction by PSIPRED server showing the predominance of extended strand.
Figure 3NcIMP-1 protein homology modelling and refinement validation using Ramachandran analysis. (a) The final tertiary model of NcIMP-1 provided by SWISS-MODEL web server, as shown in ribbon and surface. (b) Ramachandran plot analysis of the crude model using PROCHECK demonstrated 83.6%, 15.8%, 0.0%, and 0.7% of residues are assigned to most favored, additional allowed, generously allowed, and disallowed areas, respectively. (c) Upon refinement, they were improved to 90.1%, 9.9%, 0.0%, and 0.0%, correspondingly.
The final screening of shared linear B cell epitopes from N. caninum immune mapped protein-1 (IMP-1).
| Shared B cell epitopes | VaxiJen antigenicity score | AllergenFP allergenicity prediction | PepCalc water solubility prediction |
|---|---|---|---|
| VTEDGDVIVAVDE∗ | 1.0899 | No | Good |
| TADSSKGRNSESK∗ | 1.5902 | No | Good |
| MKYEQKGGKTE∗ | 1.5936 | No | Good |
| KSIKGEKTNIV∗ | 1.2111 | No | Good |
| VSPRDLELLRQA | -0.0859 | No | Good |
| AVAVAEGLQTAQK | 0.1016 | Yes | Good |
| STADSSKGRN∗ | 0.9542 | Yes | Good |
| EKAGKILVSFVPA∗ | 0.6490 | Yes | Good |
∗Shared epitopes with high antigenicity, good water solubility, and nonallergenicity.
Specific B cell linear epitopes of N. caninum immune mapped protein-1 (IMP-1) based on different physicochemical parameters predicted by the BcePred web server.
| Physicochemical parameter | B cell epitopes |
|---|---|
| Hydrophilicity | CSKSTADSSKGRNSESKATEAERA, AVTEDGDV, AVDEEDKKSIKG, SRSPEPA, VTEEGKNGDTRV, TDVTNSDGQNRREYK, VPDKGGS, SPEEEEKAGK, KYEQKGGKTE, KANEKQKY, KTCDEYEAT, PADKSKEFK, SEKKFQD, DISDNKQGL |
|
| |
| Flexibility | GVCSKSTADSSKGRNSESKA, VAVDEEDKKSIKGEK, AAVVSRSP, EVVTEEGKNGD, TDVTNSDGQNR, LYVPDKGG, QELSPEEEEKA, MKYEQKGGK, SVWKANEK, AVVPADKSKEF, EGHDLSEKK, IDISDNK, LILDGKK |
|
| |
| Accessibility | SKSTADSSKGRNSESKATEAERA, QTAQKIE, AVDEEDKKSIKGEKTNIVDE, VSRSPEPAAVIRKEEVVTEEGKNGDTRV, DLPEQVEHVSPRD, ELLRQAREQVKAT, TDVTNSDGQNRREYKPRASAY, LKQELSPEEEEKAGKI, HKSVPRMKYEQKGGKTEL, VWKANEKQKYYAAW, KTCDEYEATL, VRNWTEDMPPQV, ATLPRDRPVDL, VPADKSKEFKEGHDLSEKKFQDL, HQRLVPRGNAAK, DISDNKQGL |
|
| |
| Turns | DVTNSDGQ |
|
| |
| Exposed surface | VDEEDKKSIKGEK, QAREQVK, DGQNRREYKPRAS, KQELSPEEEEKAGK, KSVPRMKYEQKGGK, WKANEKQKYYAA, PRDRPVD, PADKSKEFKE, HDLSEKKFQDL, LDGKK |
|
| |
| Polarity | SKGRNSESKATEAERAV, VAVDEEDKKSIKGEKTNI, AVIRKEEVVTEEGKNGD, LPEQVEHVSPRDLELLRQAREQVKAT, SDGQNRREYKPRAS, KQELSPEEEEKAGKI, LHKSVPRMKYEQKGGKTE, VWKANEKQKYYA, KTCDEYE, PRDRPVDL, PADKSKEFKEGHDLSEKKFQDL, HQRLVPR, FKEDGIDI, DGKK |
|
| |
| Antigenic propensity | TRVHVSVVE, PEQVEHVSPR, GPVITDVT, YGYLLYVPDKGGSLILLWLKQ, GKILVSFVP, LHKSVPR, TVLKTCD, MPPQVFLSLLHVGPVG, RPVDLSVFSHV |
Figure 4Predicted conformational B cell epitopes of NcIMP-1 using ElliPro tool of IEDB server. Length and score of each epitope were as follows: (1) 21 residues, score: 0.712; (2) 24 residues, score: 0.697; (3) 49 residues, score: 0.662; and (4) 8 residues, score: 0.557.
Prediction of mouse MHC-I binding epitopes of N. caninum immune mapped protein-1 (IMP-1) using IEDB server followed by antigenicity, allergenicity, and toxicity screening.
| Mouse MHC-I alleles | Position | T cell peptide | Percentile rank | VaxiJen antigenicity score | AllergenFP allergenicity prediction | ToxinPred toxicity prediction |
|---|---|---|---|---|---|---|
| H2-Db | 12-23 | VEHVSPRDLELL | 2.9 | 0.1894 | Yes | Nontoxin |
| 24-35 | VVSRSPEPAAVI | 4.8 | 0.2167 | No | Nontoxin | |
| 4-15 | YVPDKGGSLILL | 5.6 | -0.8740 | No | Nontoxin | |
| 46-57 | GAPAAVTEDGDV | 5.8 | 1.2707 | Yes | Nontoxin | |
| 19-30 | VAVVPADKSKEF | 6.8 | 0.4950 | No | Nontoxin | |
|
| ||||||
| H2-Dd | 4-15 | YVPDKGGSLILL | 1.1 | -0.8740 | No | Nontoxin |
| 12-23 | VEHVSPRDLELL | 1.5 | 0.1894 | Yes | Nontoxin | |
| 24-35 | VVSRSPEPAAVI | 2.0 | 0.2167 | No | Nontoxin | |
| 41-52 | TEDMPPQVFLSL | 2.6 | 1.0264 | Yes | Nontoxin | |
| 1-12 | YLLYVPDKGGSL | 2.9 | -0.0065 | No | Nontoxin | |
|
| ||||||
| H2-Kb | 4-15 | YVPDKGGSLILL | 6.2 | -0.8740 | No | Nontoxin |
| 29-40 | AGKILVSFVPAL | 8.2 | 0.6598 | Yes | Nontoxin | |
| 11-22 | VDLSVFSHVAVV∗ | 9.1 | 0.6512 | No | Nontoxin | |
| 36-47 | FVPALHKSVPRM | 11 | -0.1124 | Yes | Nontoxin | |
| 41-52 | TEDMPPQVFLSL | 11 | 1.0264 | Yes | Nontoxin | |
|
| ||||||
| H2-Kd | 14-25 | KQKYYAAWATVL | 1.4 | 0.4647 | Yes | Nontoxin |
| 48-59 | KYEQKGGKTELL | 1.9 | 0.9165 | Yes | Nontoxin | |
| 3-14 | LYVPDKGGSLIL | 2.0 | -0.6096 | No | Nontoxin | |
| 39-50 | NWTEDMPPQVFL | 3.4 | 1.7663 | Yes | Nontoxin | |
| 2-13 | LLYVPDKGGSLI | 7.6 | -0.4493 | Yes | Nontoxin | |
|
| ||||||
| H2-Kk | 41-52 | TEDMPPQVFLSL | 0.87 | 1.0264 | Yes | Nontoxin |
| 20-31 | SKATEAERAVAV | 1.6 | 1.0536 | Yes | Nontoxin | |
| 18-29 | SESKATEAERAV | 2.0 | 1.0414 | Yes | Nontoxin | |
| 25-36 | EEEKAGKILVSF∗ | 2.2 | 1.1575 | No | Nontoxin | |
| 29-40 | DEYEATLCVRNW | 2.2 | 1.1189 | No | Nontoxin | |
|
| ||||||
| H2-Ld | 41-52 | TEDMPPQVFLSL | 0.61 | 1.0264 | Yes | Nontoxin |
| 44-55 | MPPQVFLSLLHV | 1.1 | 0.6408 | No | Nontoxin | |
| 5-16 | LPRDRPVDLSVF∗ | 1.3 | 0.9249 | No | Nontoxin | |
| 5-16 | VPDKGGSLILLW | 1.5 | -0.9925 | Yes | Nontoxin | |
| 19-30 | VAVVPADKSKEF | 1.5 | 0.4950 | No | Nontoxin | |
|
| ||||||
| H-2-Q1 | 4-15 | YVPDKGGSLILL | 3.0 | -0.8740 | No | Nontoxin |
| 7-18 | SVWKANEKQKYY | 3.9 | 0.2189 | No | Nontoxin | |
| 41-52 | VTNSDGQNRREY | 4.1 | 0.3669 | No | Nontoxin | |
| 1-12 | YLLYVPDKGGSL | 5.7 | -0.0065 | No | Nontoxin | |
| 10-21 | KANEKQKYYAAW | 5.9 | 0.5640 | No | Nontoxin | |
|
| ||||||
| H-2-Q2 | 41-52 | TEDMPPQVFLSL | 0.78 | 1.0264 | Yes | Nontoxin |
| 38-49 | RNWTEDMPPQVF | 1.1 | 1.2711 | No | Nontoxin | |
| 27-38 | REQVKATGGPVI | 1.3 | 0.9078 | Yes | Nontoxin | |
| 25-36 | EEEKAGKILVSF | 1.3 | 1.1575 | No | Nontoxin | |
| 29-40 | DEYEATLCVRNW∗ | 1.4 | 1.1189 | No | Nontoxin | |
∗Potential qualified epitopes.
Prediction of mouse MHC-II binding epitopes of N. caninum immune mapped protein-1 (IMP-1) using IEDB web server followed by screening for antigenicity, allergenicity, and IFN-γ/IL-4 induction.
| Mouse MHC-II alleles | Position | T cell peptide | Percentile rank | VaxiJen antigenicity score | AllergenFP allergenicity prediction | IFN- | IL-4 induction |
|---|---|---|---|---|---|---|---|
| H2-IAb | 13-27 | EKQKYYAAWATVLKT | 0.5 | 0.0589 | No | Positive | Positive |
| 12-26 | NEKQKYYAAWATVLK | 0.58 | 0.1720 | Yes | Positive | Positive | |
| 11-25 | ANEKQKYYAAWATVL | 0.72 | 0.4536 | No | Positive | Positive | |
| 14-28 | KQKYYAAWATVLKTC | 0.8 | 0.1605 | No | Positive | Positive | |
| 15-29 | QKYYAAWATVLKTCD | 0.91 | -0.0727 | Yes | Positive | Positive | |
| 39-53 | QKIEAVTGAPAAVTE | 0.94 | 0.3219 | No | Positive | Positive | |
|
| |||||||
| H2-IAd | 13-27 | EKQKYYAAWATVLKT | 1.62 | 0.0589 | No | Positive | Positive |
| 14-28 | KQKYYAAWATVLKTC | 1.75 | 0.1605 | No | Positive | Positive | |
| 15-29 | QKYYAAWATVLKTCD | 2.10 | -0.0727 | Yes | Positive | Positive | |
| 12-26 | NEKQKYYAAWATVLK | 2.18 | 0.1720 | Yes | Positive | Positive | |
| 13-27 | LSVFSHVAVVPADKS | 2.77 | 0.4540 | No | Negative | Positive | |
| 12-26 | DLSVFSHVAVVPADK | 3.2 | 0.5379 | No | Negative | Negative | |
|
| |||||||
| H2-IEd | 35-49 | SFVPALHKSVPRMKY | 1.5 | 0.0715 | No | Positive | Positive |
| 34-48 | VSFVPALHKSVPRMK | 2.05 | 0.0013 | No | Positive | Positive | |
| 36-50 | FVPALHKSVPRMKYE | 2.35 | 0.1416 | No | Positive | Positive | |
| 2-16 | IEDKWSVWKANEKQK | 2.6 | 0.2682 | No | Negative | Positive | |
| 13-27 | EKQKYYAAWATVLKT | 2.75 | 0.0589 | No | Positive | Positive | |
| 14-28 | KQKYYAAWATVLKTC | 2.9 | 0.1605 | No | Negative | Positive | |
Prediction of top ten cytotoxic T lymphocyte (CTL) epitopes of N. caninum immune mapped protein-1 (IMP-1) using CTLPred web server with antigenicity, allergenicity, and hydrophobicity screening.
| Rank | Start position | Peptide sequence | Score (ANN/SVM) | VaxiJen antigenicity score | AllergenFP allergenicity prediction | Hydrophobicity (%) |
|---|---|---|---|---|---|---|
| 1 | 124 | DLADLPEQV | 0.93/1.0930182 | -0.5829 | Yes | 55.56 |
| 2 | 230 | EQKGGKTEL | 0.93/0.94425972 | 0.6914 | Yes | 11.11 |
| 3 | 86 | SRSPEPAAV | 0.50/1.3343562 | 0.1781 | No | 55.56 |
| 4 | 356 | VPRGNAAKL | 1.00/0.80563294 | 0.4124 | No | 55.56 |
| 5 | 23 | TEAERAVAV | 0.85/0.93975112 | 0.9334 | Yes | 55.56 |
| 6 | 76 | IVDEAAAAV | 0.76/0.85800815 | 0.3109 | Yes | 77.78 |
| 7 | 303 | ATLPRDRPV | 0.41/1.1165353 | 1.1887 | Yes | 55.56 |
| 8 | 267 | TCDEYEATL | 0.95/0.56175719 | 1.2626 | Yes | 22.22 |
| 9 | 149 | QVKATGGPV∗ | 0.16/1.2059993 | 0.9845 | No | 44.44 |
| 10 | 273 | ATLCVRNWT | 0.95/0.37756272 | 1.0445 | Yes | 44.44 |
∗Qualified epitope.